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ABSTRACT 
Penicillium marneffei is a dimorphic fungus that can cause sys- 
temic mycosis in humans. It is endemic in Southeast Asia, the 
Guangxi province of China, Hong Kong, and Taiwan. Prior to 
the epidemic of human immunodeficiency virus (HIV), penicil- 
liosis was a rare event. The incidence of this fungal infection 
has increased markedly during the past few years, paralleling 
the incidence of HIV infection. The patients usually present with 
fever, anemia, weight loss, skin lesions, generalized lym- 
phadenopathy, and hepatomegaly. The skin lesions are most 
commonly papules with central necrotic umbilication. The aver- 
age number of CD4+ T lymphocytes at presentation is 64 
cells/mm3. The fungus is usually sensitive to amphotericin B, 
itraconazole, and ketoconazole. The response to antifungal 
treatment is good if the treatment is started early. After the ini- 
tial treatment the patient may need to take an antifungal drug 
as secondary prophylaxis for life. New tests for the laboratory 
diagnosis of penicilliosis have been reported. Further studies of 
these tests, as well as the epidemiology, natural history and 
management of this potentially fatal systemic fungal infection 
are needed. 
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Penicillium marnefSei is a dimorphic fungal pathogen 
which can cause disease in both immunocompetent and 
immunocompromised hosts. It is endemic in Southeast 
Asia, the Guangxi province of China, Hong Kong, and Tai- 
wan.‘-* The fungus was first isolated from a bamboo rat 
in Vietnam in 1~56.~ The first naturally infected case was 
an American missionary with Hodgkin’s disease who had 
been living in Southeast Asia.6 The second was reported 
in 1984 in another American who also had travelled in 
the Far East.’ Also in 1984, five cases were reported from 
*Department of Medicine, Faculty of IMedicine, Chiang Mai University 
Hospital, Chiang Mai, Thailand. 
Presented at the 8th International Congress on Infectious Diseases, 
Boston, Massachusetts, May 15-18,1998. 
Address correspondence to Dr. Thira Sirisanthana, Department of Med- 
icine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, 
Thailand. 
48 
Thailand.8 The first eight Chinese cases were reported 
in 1985 from the Guangxi province of China.9 They were 
diagnosed between 1964 and 1983. More cases were sub- 
sequently reported from the same area in China and from 
Hong Kong.2J0-16 
Less than 40 cases of penicilliosis due to E! mamef- 
fei were reported prior to the human immunodeficiency 
virus (HIV) epidemic. The number of cases of penicillio- 
sis has increased markedly over the past few years. This 
increase is mainly due to infection in patients infected 
with HIV.1,17-38 The majority of patients have been 
reported from Thailand. 1,29 Between 1991 and 1997, peni- 
cilliosis was diagnosed in 1173 HIV-infected patients at 
Chiang Mai University Hospital alone. Figure 1 shows the 
number of patients by year of diagnosis. The increase in 
the number of cases over the years paralleled the inci- 
dence of HlV infection in northern Thailand. In this area, 
penicilliosis is the third most common opportunistic 
infection in late HIV disease, after tuberculosis and cryp- 
tococcosis.’ Other countries in the endemic area that 
reported cases of penicilliosis in HIV-infected patients 
were Hong Kong,21-23,30,37 Taiwan, *z3* and Malaysia.31 Cases 
of penicilliosis also have been reported in HIV-infected 
individuals from the United States,” the United King- 
dom I8 the Netherlands,20,36 
Swit$erland,27,33~35 Sweden,32 
Italy, ‘* France,25 Germany,26 
and Australia,28 following vis- 
its to the endemic region. 
Two cases of laboratory-acquired infection have been 
reported. Professor Segretain, who identified I? marneffei 
as a new species of Penicillium, reported the first infec- 
tion in humans in 1959.*“,37 He accidentally inoculated 
himself during an experiment and developed a nodule 
at the site of inoculation, lymphangitis, and lymph- 
adenopathy. The second case was an HIV-infected Con- 
golese man who attended a 4-month course in tropical 
microbiology at the Institut Pasteur in Paris and was diag- 
nosed as having penicilliosis shortly after the course.40 
The patient had never visited Asia. In the building where 
he attended class at the Institut Pasteur, a mycology 
course was being taught. Part of the course involved the 
morphologic identification of E! mamefSei. The patient 
entered the mycology classroom on two occasions to see 
a friend. The authors who reported the latter case 
suggested that cultures of t! marneffei be treated as 
pathogens of biohazard level 3.*l 
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Figure 1. Year of diagnosis and number of patients with fenicillium 
marneffei infection diagnosed at Chiang Mai University Hospital. 
NATURAL HISTORY 
Many critical features of the natural reservoir, mode of 
transmission, and natural history of I! mameffei infection 
remain unknown. The fungus was fast isolated from bam- 
boo rats (Rhkomys sinensis) in Vietnam in 1956.5,42 In 
two reports from the Guangxi province of China, J? marn- 
effei was isolated from the internal organs of 18 of 19 and 
15 of 16 Rhizomys pruinosus, another species of bam- 
boo rats.43,44 These animals were infected with the fun- 
gus but showed no signs of illness. Another publication 
reported the isolation of I! marneffei from 39 of 43 bam- 
boo rats (37 of 41 R.pruinosus and 2 of 2 R. sinensis).2 
A further survey from the same area in China revealed the 
isolation of the fungus from 114 of 179 (63.7%) R. pru- 
inosus.45 A study of bamboo rats in central Thailand in 
1987 showed that the fungus could be isolated from 6 of 
8 R. pruinosus, and 6 of 31 of another species of bam- 
boo rat, Cannomys bada%.*’ More recently in Chiang 
Mai, I? marneffei was isolated from 3 of 10 C. badius and 
yet another species of bamboo rat, Rhizomys sumatrensis 
(from 13 of 14 animals studied).*’ 
Since bamboo rats usually live near the forest and have 
limited contact with people, it is believed that both humans 
and bamboo rats are infected with I? marneffei from a 
common source, rather than the patients being infected 
from the rats. Penicillium mameffei, like other endemic 
fungal pathogens, may be predominantly a soil fungus. A 
case-control study was carried out in Chiang Mai, com- 
paring risk-related behavior and exposures in 80 incident 
cases of penicilliosis in HIV-infected patients and 160 HIV- 
infected control patients who did not have P marneffei 
infection.48 It was found that patients with a recent history 
of occupational or other exposure to soil, especially dur- 
ing the rainy season, were more likely to present with peni- 
cilliosis. History of exposure to, or consumption of bamboo 
rats was not a risk factor for infection. The data suggested 
that patients acquired the fungal infection from a reser- 
voir of organisms in the soil. In another study from Chiang 
Mai, it was found that penicilliosis in HIV-infected patients 
was significantly more likely to occur in the rainy season, 
May to October. 49 This suggested that there might be an 
expansion of that environmental reservoir with favorable 
conditions for growth during these rainy months. It should 
be noted that attempts to isolate the fungus from 67 soil 
samples from the residential areas of patients with peni- 
cilliosis yielded negative results.*’ Additionally, the authors 
cultured many samples of bamboo and vegetation from 
the environment where human cases had occurred; all 
were negative.*’ 
The exact route of infection of P marneffei in 
humans is not known. By analogy with other endemic 
fitngal pathogens, such as Coccidioides immitis and Histo- 
plasma capsulatum, it is likely that P marnefii conidia 
may be inhaled from an environmental reservoir. The fun- 
gus proliferates in macrophages and is disseminated 
throughout the body, especially to the reticuloendothelial 
system. Consequently in human infection, the liver, lymph 
nodes, bone marrow, and spleen are commonly involved. 
A small inoculum, perhaps only a few conidia, may be 
sufficient to cause symptomatic infection in immuno- 
suppressed individuals. Attempts to culture the fungus 
from air from the patients’ homes, using high-volume 
air samplers, have repeatedly yielded negative results. In 
the report of the Congolese patient who acquired the 
infection at the Institut Pasteur, air samples taken in the 
building during that period also did not yield any E! 
mameffei.40 
It is likely that in endemic areas, such as northern 
Thailand, a certain proportion of the population is 
infected, but remains asymptomatic. Patients have been 
reported with long periods of asymptomatic infection 
before presentation with P mamefS.28 In other cases, the 
clinical manifestation of disseminated infection occurred 
within a few weeks of exposure to the fungus.” Report 
of penicilliosis in HIV-infected infants also suggests that 
the period between infection and clinical manifestation 
sometimes may be brief.29 
MYCOLOGY 
Penicillium marneffei can be readily cultured from vari- 
ous clinical specimens. Bone marrow culture is the most 
sensitive (lOO%), followed by culture of specimens from 
skin biopsy (90%) and blood culture (76%).l It grows as 
a mold at 25°C on Sabouraud dextrose agar. Mold-to-yeast 
conversion is achieved by subculturing the fungus onto 
brain-heart-infusion (BHI) agar and incubating at 37”C.6,39 
In the mycelial phase, the fungus typically produces red 
pigment, which diffuses into the agar.Young colonies are 
white and downy The color of the more mature colonies 
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may be yellow or yellowish green; and may then turn to 
gray, green, or brown. 5o Aged colonies are deep red. Micro- 
scopic examination of the mycelia shows typical struc- 
tures of Penicillium species. They are septate hyphae with 
lateral and terminal conidiophores or penicilli. Penicilli 
are monoverticillate or biverticillate, with either symmet- 
rical or asymmetrical branches.6,51 Metulae bear 3 to 16 
phialides, each of which produces long basipetal 
unbranched chains of conidia. Spiral hyphae are some- 
times present.6 Colonies of the yeast form of the fungus 
have a wrinkled or cerebriform surface. Their color is light 
tan to brown on BHI, beer wort, or blood agar.6z50 Micro- 
scopically, the yeast cells are globose to oval, measuring 
2 to 3 microns by 2 to 6.5 microns with single septum.50 
Arthroconidia-like cells and short septate hyphae are seen 
in colonies subcultured from the mycelial phase.‘,*’ 
CLINICAL MANIFESTATIONS 
The clinical features of the first 92 patients with peni- 
cilliosis diagnosed at Chiang Mai University Hospital have 
been reported.’ The clinical presentation of another 74 
HIV-infected patients with penicilliosis (64 male; 10 
female), who were diagnosed between November 1993 
and January 1996, recently were reported.5z Of these, 72 
acquired HIV infection from heterosexual contact. Table 
1 shows the symptoms and signs of the patients at pre- 
sentation. The majority presented with fever, weight loss, 
skin lesions, generalized lymphadenopathy, and 
hepatomegaly. Sixty-three patients (85%) had skin lesions. 
They were usually found on the face and neck, upper 
extremities, and trunk. The typical lesions were papules, 
often with a centralized umbilication or necrosis (Figure 
2). These lesions are not distinguishable from those seen 
in disseminated cryptococcosis or disseminated histo- 
plasmosis in HIV-infected patients. Respiratory symptoms 
(e.g., cough and shortness of breath) occur in about one- 
third of patients. The chest roentgenograms in such cases 
usually show mixed alveolar and interstitial infiltrates. 
Clinical features in HIV-infected children with penicil- 
liosis are identical to those seen in adults.29 
Table 1. Clinical Presentation of 74 HIV-Infected 
Patients with Penicilliosis due to Penicillium marneffei 
Symptom Number (%) 
Fever 
Weight loss 
Cough 
Diarrhea 
Skin lesions 
Generalized lymphadenopathy 
Hepatomegaly 
Splenomegaly 
71 (96.0) 
71 (96.0) 
23 (31 .l) 
11 (14.9) 
63 (85.1) 
62 (83.8) 
48 (64.9) 
17 (23.0) 
Figure 2. Skin lesion of a HIV-infected patient with Penicillium marn- 
effei infection. They usually are papules with central necrosis. 
Penicilliosis occurs late in the course of HIV infec- 
tion. The number of patients who had HIV-related con- 
ditions at or before presentation is shown in Table 2. The 
average number of CD4+ T lymphocytes in these patients 
was 63.8 cells/mm3. A simple bedside technique has been 
described that allows physicians to make a presumptive 
diagnosis of the infection several days before the results 
of fungal cultures are available.’ This is done by micro- 
scopic examination of the Wright’s-stained samples of 
the touch smears of skin, or lymph-node biopsy speci- 
mens, or bone-marrow aspirate. Many intracellular and 
extracellular yeast cells can be seen with this technique. 
Some of these cells have clear central septation, which is 
a characteristic feature of P marneffei (Figure 3). In HIV- 
infected individuals in an endemic area, the differential 
diagnoses of penicilliosis are tuberculosis, disseminated 
histoplasmosis, and disseminated cryptococcosis. Physi- 
cians in the West need to consider penicilliosis in a 
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Table 2. HIV-Related Conditions at or before 
Presentation with Penicilliosis in 74 HIV-Infected Patients 
Condition Number of Patients 
emptive treatment with an antifungal agent similar to iso- 
niazid treatment in asymptomatic persons with a posi- 
tive tuberculin skin test. 
Herpes zoster infection 9 
Oral hairy leukoplakia 6 
Pneumocystis carinii pneumonia 5 
Extrapulmonary tuberculosis 2 
Pulmonary tuberculosis 2 
Chronic diarrhea (>I mo) 1 
Candida esophagitis 1 
Cerebral toxoplasmosis 1 
Pulmonary nocardiosis 1 
patient who presents with fever of unknown origin if 
the patient has migrated from or travelled in an endemic 
area and especially if he or she is also infected with 
~~y24-28.38 
LABORATORY DIAGNOSIS 
Laboratory findings reflect the disseminated nature of 
the infection. They include anemia and elevation of 
hepatic enzymes. The diagnosis is usually confirmed by 
histopathologic section and by culturing the fungus from 
the blood, skin biopsy specimens, bone marrow, or lymph 
nodes.’ Several tests to detect the antibody to E! mam- 
efsei in infected individuals have been developed,24,53-55 
as well as tests to detect I! marneffei antigen.j6 Clinical 
trials are needed to show usefulness of these tests in the 
diagnosis of active penicilliosis or to predict relapses. 
Several specific protein antigens of iF! marneffei have 
been identified.55 This may lead to the development of a 
test that can be used to identify HIV-infected individu- 
als who are infected with I! marneffei but who are still 
asymptomatic. These persons may then benefit from pre- 
Figure 3. Photomicrograph of Wright’s-stained touch smear of skin 
biopsy specimen from an HIV-infected patient with Penicillium mar- 
neffei infection. Note oval yeast cells with clear central septation in a 
macrophage (original magnification, x 1000). 
TREATMENT 
Penicilliosis due to I? marnefii is a potentially fatal sys- 
temic fungal infection. The mortality rate of patients with 
penicilliosis had been high,2,8,9*23 mostly because of a lack 
of timely diagnosis. The response to therapy was much 
better in the hospital where physicians were aware of 
the clinical features of the infection and the diagnosis 
was made early The fungus was sensitive to amphotericin 
B, itraconazole, ketoconazole, and miconazole.57 The 
authors studied the efficacy of treating patients with 
amphotericin at a dose of 0.6 mg/kg per day for 2 weeks, 
followed by 400 mg of itraconazole per day orally in two 
divided doses for the next 10 weeks.58 Seventy-two of 
the 74 patients (97.3%) responded to treatment. One of 
the remaining two patients was lost to follow-up after 
the second week, and the other died of bacterial sepsis 
after 10 weeks of treatment. There were no serious 
adverse drug effects. It was concluded that the regimen 
was effective and safe in treating penicilliosis in HIV- 
infected individuals. 
In one study, it was found that 12 of 40 patients who 
responded to initial treatment relapsed within 6 months.j7 
Thus it is recommended that, after initial treatment, 
patients be given itraconazole 200 mg/day as secondary 
preventive treatment, for the rest of their lives. 
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